Gabrielle Emanuel

In Zambia, we met people who are HIV positive, couldn't get drugs to suppress the virus after U.S. aid cuts and were seeing symptoms. We checked in on them — and the man who's been their champion.

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of effort will be a model for how it does global health work in the future.

Why cholera is striking in Africa. It's a disease that's easy to control with proper treatment. But without medical care, patients can perish quickly.

The virus took the world by storm. It was declared a "public health emergency of continental concern." What's the current status? With the U.S. aid cuts, one doctor says, "We're flying blind."

A year ago, on Aug. 14, 2024, the World Health Organization declared mpox a Public Health Emergency of International Concern. Why are health experts so frustrated by the world's response?

It's the 40th anniversary of the superstar concert to raise money for the famine in Ethiopia — and of the creation of a U.S. program called FEWS NET to prevent future famines.

The therapeutic food is designed to bring malnourished kids back from the brink. A new order from the U.S. after months of mixed signals is good news for the Rhode Island factory that makes it.

Charities usually like to talk to the public about their good works. In the wake of the Trump aid cuts, there's a new approach: "anticipatory silence." It's controversial.

Founded by George W. Bush, the President's Emergency Plan for AIDS Relief was taken out of the list of agencies that lost previously pledged funds. But its future is far from certain.

It costs nearly $100 million a year to maintain global stockpiles of vaccines for Ebola, cholera, meningitis and yellow fever in case of emergency. A new study estimates how many lives they've saved.